Target Name: PHKA1-AS1
NCBI ID: G101928259
Review Report on PHKA1-AS1 Target / Biomarker Content of Review Report on PHKA1-AS1 Target / Biomarker
PHKA1-AS1
Other Name(s): PHKA1 antisense RNA 1 (non-protein coding) | PHKA1 antisense RNA 1

PHKA1-AS1: A Potential Drug Target and Biomarker

PHKA1-AS1, also known as PHKA1 antisense RNA 1 (non-protein coding), is a molecule that has been identified as a potential drug target and biomarker. PHKA1-AS1 is a non-protein coding RNA molecule that is expressed in various tissues and cell types in the human body. Its function is not well understood, but research has shown that it plays an important role in cell signaling and regulation.

One of the key features of PHKA1-AS1 is its unique structure. PHKA1-AS1 is a double-stranded RNA molecule that has a length of approximately 240 nucleotides. It has a conserved structure at its 5' and 3' ends, but the middle region is unique. The middle region of PHKA1-AS1 is composed of a series of alternating regions that have different frequencies of guanine and cytosine nucleotides.

One of the key functions of PHKA1-AS1 is its ability to interact with other molecules. Studies have shown that PHKA1-AS1 can interact with various proteins, including casein kinase (CK) 2, which is a protein that is involved in cell signaling and regulation. These interactions may play a role in the function of PHKA1-AS1 and could be potential drug targets.

Another potential function of PHKA1-AS1 is its role in cell signaling pathways. Studies have shown that PHKA1-AS1 is involved in various signaling pathways, including the NF-kappa pathway, the Wnt pathway, and the Hedgehog pathway. These signaling pathways are important for cell growth, differentiation, and survival, and may be potential targets for drugs that are designed to disrupt these pathways.

In addition to its potential role in cell signaling, PHKA1-AS1 is also a potential biomarker. Studies have shown that PHKA1-AS1 is expressed in various tissues and cell types in the human body, including the brain, heart, and liver. Its expression may be a useful biomarker for certain diseases, such as cancer, neurodegenerative diseases, and cardiovascular diseases.

Another potential function of PHKA1-AS1 is its role in the regulation of gene expression. Studies have shown that PHKA1-AS1 can interact with various transcription factors, including DNA-binding proteins. These interactions may play a role in the regulation of gene expression and could be potential targets for drugs that are designed to disrupt these interactions.

Overall, PHKA1-AS1 is a molecule that has a unique structure and function. Its ability to interact with other molecules and participate in various signaling pathways makes it a potential drug target and biomarker. Further research is needed to fully understand its role in the human body and to develop drugs that can target it effectively.

Protein Name: PHKA1 Antisense RNA 1

The "PHKA1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PHKA1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PHKA2 | PHKA2-AS1 | PHKB | PHKG1 | PHKG2 | PHLDA1 | PHLDA2 | PHLDA3 | PHLDB1 | PHLDB2 | PHLDB3 | PHLPP1 | PHLPP2 | Phosphatidylinositol 3-kinase (PI3K) | Phosphatidylinositol 3-kinase complex (PIK3C3, PIK3R4) | Phosphatidylinositol 4-Kinase (PI4K) | Phosphatidylinositol 4-Kinase beta (PI4K-beta) | Phosphatidylinositol 4-phosphate 5-kinase | Phosphatidylinositol N-acetylglucosaminyltransferase | Phosphatidylinositol-5-phosphate 4-kinase | PHOSPHO1 | PHOSPHO2 | PHOSPHO2-KLHL23 | Phosphodiesterase | Phosphodiesterase 1 (PDE1) | Phosphodiesterase 6 (PDE6) | Phosphodiesterase 8 (nons | Phosphodiesterase IV (PDE4) | Phosphoglucomutase 5 pseudogene 1 | Phosphoglycerate kinase | Phospholipase A | Phospholipase A2 | Phospholipase A2, Cytosolic | Phospholipase A2, Secretory (sPLA2) | Phospholipase C | Phospholipase D | Phosphorylase kinase | PHOX2A | PHOX2B | PHPT1 | PHRF1 | PHTF1 | PHTF2 | PHYH | PHYHD1 | PHYHIP | PHYHIPL | PHYKPL | PI15 | PI16 | PI3 | PI4K2A | PI4K2B | PI4KA | PI4KAP1 | PI4KAP2 | PI4KB | PIANP | PIAS1 | PIAS2 | PIAS3 | PIAS4 | PIBF1 | PICALM | PICART1 | PICK1 | PICSAR | PID1 | PIDD1 | PIERCE1 | PIERCE2 | PIEZO1 | PIEZO2 | PIF1 | PIFO | PIGA | PIGB | PIGBOS1 | PIGC | PIGF | PIGG | PIGH | PIGK | PIGL | PIGM | PIGN | PIGO | PIGP | PIGQ | PIGR | PIGS | PIGT | PIGU | PIGV | PIGW | PIGX | PIGY | PIGZ | PIH1D1 | PIH1D2